This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Medicaid Drug Rebate Program (MDRP) Summit 2024
September 23-25, 2024
Delivered as a Hybrid EventChicago Marriott Downtown Magnificent Mile, Chicago, IL

Brian McCartney
Vice President Strategic Innovation & Policy at McKesson


Brian has responsibility to proactively monitor drug pricing reform issues – including legislative, regulatory and administrative actions at the federal and state level – that could impact strategic and business outcomes for McKesson and our customers, partners and other industry stakeholders in the U.S. pharmaceutical value chain. Brian assess’ financial implications for McKesson, and develops strategies and operational solutions to manage risk and drive business value, harnessing the breadth and depth of enterprise assets and capabilities.

Brian comes to McKesson with over 17 years of pharmaceutical manufacturer experience in government pricing and policy at J&J, Endo Pharmaceuticals and most recently at AstraZeneca. During his tenure at AstraZeneca, Brian helped the company navigate drug pricing reform by strategically partnering with Policy, Finance, Account Teams and Contract Strategy to mitigate the impacts of the Inflation Reduction Act, AMP Cap Removal etc. Brian is a subject matter expert in government price reporting that gives him a deep understanding of the U.S. pharmaceutical supply chain, including 340B, buy and bill and diverse payer segments.

Brian McCartney's Network

Agenda Sessions

  • Closed-Door Executive Strategy Summit